STOCK TITAN

[8-K] Labcorp Holdings Inc. Reports Material Event

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
8-K
Rhea-AI Filing Summary

Labcorp Holdings (NYSE: LH) filed a Form 8-K disclosing that it will release its second-quarter 2025 financial results before market open on Thursday, July 24, 2025. Management will host a conference call and webcast at 9 a.m. ET the same day. The filing contains no preliminary results, strategic updates or other material information.

Labcorp Holdings (NYSE: LH) ha presentato un modulo 8-K comunicando che pubblicherà i risultati finanziari del secondo trimestre 2025 prima dell'apertura del mercato di giovedì 24 luglio 2025. La direzione terrà una conference call e una webcast alle 9:00 ET dello stesso giorno. La comunicazione non include risultati preliminari, aggiornamenti strategici o altre informazioni rilevanti.

Labcorp Holdings (NYSE: LH) presentó un formulario 8-K informando que publicará sus resultados financieros del segundo trimestre de 2025 antes de la apertura del mercado el jueves 24 de julio de 2025. La dirección realizará una llamada conferencia y una transmisión en vivo a las 9 a.m. ET ese mismo día. El informe no contiene resultados preliminares, actualizaciones estratégicas ni otra información relevante.

Labcorp Holdings (NYSE: LH)2025년 2분기 재무 실적2025년 7월 24일 목요일 시장 개장 전 발표할 것임을 알리는 Form 8-K를 제출했습니다. 경영진은 같은 날 오전 9시(동부시간)에 컨퍼런스 콜과 웹캐스트를 진행할 예정입니다. 제출된 문서에는 예비 실적, 전략 업데이트 또는 기타 중요한 정보가 포함되어 있지 않습니다.

Labcorp Holdings (NYSE : LH) a déposé un formulaire 8-K annonçant qu'elle publiera ses résultats financiers du deuxième trimestre 2025 avant l'ouverture des marchés le jeudi 24 juillet 2025. La direction tiendra une conférence téléphonique et une webdiffusion à 9h00 ET le même jour. Le dépôt ne contient aucun résultat préliminaire, mise à jour stratégique ou autre information importante.

Labcorp Holdings (NYSE: LH) hat ein Formular 8-K eingereicht, in dem bekanntgegeben wird, dass die Finanzergebnisse für das zweite Quartal 2025 vor Markteröffnung am Donnerstag, den 24. Juli 2025 veröffentlicht werden. Das Management wird am selben Tag um 9 Uhr ET eine Telefonkonferenz und eine Webcast veranstalten. Die Einreichung enthält keine vorläufigen Ergebnisse, strategischen Updates oder sonstige wesentliche Informationen.

Positive
  • None.
Negative
  • None.

Labcorp Holdings (NYSE: LH) ha presentato un modulo 8-K comunicando che pubblicherà i risultati finanziari del secondo trimestre 2025 prima dell'apertura del mercato di giovedì 24 luglio 2025. La direzione terrà una conference call e una webcast alle 9:00 ET dello stesso giorno. La comunicazione non include risultati preliminari, aggiornamenti strategici o altre informazioni rilevanti.

Labcorp Holdings (NYSE: LH) presentó un formulario 8-K informando que publicará sus resultados financieros del segundo trimestre de 2025 antes de la apertura del mercado el jueves 24 de julio de 2025. La dirección realizará una llamada conferencia y una transmisión en vivo a las 9 a.m. ET ese mismo día. El informe no contiene resultados preliminares, actualizaciones estratégicas ni otra información relevante.

Labcorp Holdings (NYSE: LH)2025년 2분기 재무 실적2025년 7월 24일 목요일 시장 개장 전 발표할 것임을 알리는 Form 8-K를 제출했습니다. 경영진은 같은 날 오전 9시(동부시간)에 컨퍼런스 콜과 웹캐스트를 진행할 예정입니다. 제출된 문서에는 예비 실적, 전략 업데이트 또는 기타 중요한 정보가 포함되어 있지 않습니다.

Labcorp Holdings (NYSE : LH) a déposé un formulaire 8-K annonçant qu'elle publiera ses résultats financiers du deuxième trimestre 2025 avant l'ouverture des marchés le jeudi 24 juillet 2025. La direction tiendra une conférence téléphonique et une webdiffusion à 9h00 ET le même jour. Le dépôt ne contient aucun résultat préliminaire, mise à jour stratégique ou autre information importante.

Labcorp Holdings (NYSE: LH) hat ein Formular 8-K eingereicht, in dem bekanntgegeben wird, dass die Finanzergebnisse für das zweite Quartal 2025 vor Markteröffnung am Donnerstag, den 24. Juli 2025 veröffentlicht werden. Das Management wird am selben Tag um 9 Uhr ET eine Telefonkonferenz und eine Webcast veranstalten. Die Einreichung enthält keine vorläufigen Ergebnisse, strategischen Updates oder sonstige wesentliche Informationen.

0000920148false00009201482025-06-262025-06-26

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C.  20549

FORM 8-K

CURRENT REPORT

PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

June 26, 2025
(Date of earliest event reported)
LABCORP HOLDINGS INC.
(Exact Name of Registrant as Specified in its Charter)
Delaware1-1135399-2588107
(State or other jurisdiction of Incorporation)(Commission File Number)(I.R.S. Employer Identification No.)

358 South Main Street 
Burlington,North Carolina27215
(Address of principal executive offices)(Zip Code)
(Registrant’s telephone number including area code) 336-229-1127
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
Written communication pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Securities registered pursuant to Section 12(b) of the Exchange Act.
Title of each classTrading SymbolName of exchange on which registered
Common Stock, $0.10 par valueLHNew York Stock Exchange
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).             
Emerging growth company
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.



Item 7.01Regulation FD Disclosure.
Labcorp Holdings Inc. (NYSE: LH), a global leader of innovative and comprehensive laboratory services, will release its financial results for the second quarter of 2025 before the market opens on Thursday, July 24, 2025, and will host a conference call and webcast beginning at 9 a.m. ET that day to discuss the results. The earnings press release and accompanying financial information will be posted on the Labcorp Investor Relations website.
Item 9.01Financial Statements and Exhibits.
ExhibitExhibit Name
Exhibit 99.1
Exhibit 104Cover Page Interactive Data File (embedded within the Inline XBRL document)




SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

LABCORP HOLDINGS INC.
Registrant

Date: June 26, 2025By:/s/ SANDRA D. VAN DER VAART
 Sandra D. van der Vaart
  Executive Vice President, Chief Legal Officer and Corporate Secretary

FAQ

When will LH release its Q2 2025 earnings?

Labcorp will issue Q2 2025 financial results before the market opens on July 24, 2025.

What time is the LH Q2 2025 earnings conference call?

The call and webcast begin at 9 a.m. ET on July 24, 2025.

Does the 8-K provide any preliminary Q2 2025 financial figures for LH?

No. The filing only announces the release date and webcast details; no financial metrics were disclosed.
Labcorp Holdings Inc

NYSE:LH

LH Rankings

LH Latest News

LH Latest SEC Filings

LH Stock Data

21.92B
83.36M
0.34%
96.06%
2.21%
Diagnostics & Research
Services-medical Laboratories
Link
United States
BURLINGTON